132 related articles for article (PubMed ID: 3445287)
1. Synthesis and evaluation of bromoacetoxy 4-androsten-3-ones as active site-directed inhibitors of human placental aromatase.
Numazawa M; Tsuji M; Osawa Y
Steroids; 1986; 48(5-6):347-59. PubMed ID: 3445287
[TBL] [Abstract][Full Text] [Related]
2. Time-dependent inactivation of human placental aromatase by bromoacetoxy 4-androsten-3-ones in the presence of reduced nicotinamide adenine dinucleotide phosphate (NADPH).
Numazawa M; Tsuji M; Mutsumi A; Nagaoka M
Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):735-7. PubMed ID: 2752485
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 16 alpha-bromoacetoxy androgens and 17 beta-bromoacetylamino-4-androsten-3-one: potential affinity labels of human placental aromatase.
Numazawa M; Osawa Y
Steroids; 1981 Aug; 38(2):149-59. PubMed ID: 7303027
[TBL] [Abstract][Full Text] [Related]
4. 3 beta-hydroxyandrost-4-en-6-one derivatives as aromatase inhibitors.
Numazawa M; Mutsumi A; Tsuji M
Steroids; 1989 Sep; 54(3):299-311. PubMed ID: 2588304
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of 6-substituted androst-4-ene analogs as aromatase inhibitors.
Numazawa M; Kamiyama T; Tachibana M; Oshibe M
J Med Chem; 1996 May; 39(11):2245-52. PubMed ID: 8667367
[TBL] [Abstract][Full Text] [Related]
6. 6 alpha,7 alpha-cyclopropane derivatives of androst-4-ene: a novel class of competitive aromatase inhibitors.
Numazawa M; Mutsumi A
Biochem Biophys Res Commun; 1991 May; 177(1):401-6. PubMed ID: 2043124
[TBL] [Abstract][Full Text] [Related]
7. Mechanism for aromatase inactivation by a suicide substrate, androst-4-ene-3,6,17-trione. The 4 beta, 5 beta-epoxy-19-oxo derivative as a reactive electrophile irreversibly binding to the active site.
Numazawa M; Mutsumi A; Tachibana M
Biochem Pharmacol; 1996 Oct; 52(8):1253-9. PubMed ID: 8937433
[TBL] [Abstract][Full Text] [Related]
8. A time-dependent inactivation of aromatase by 19-substituted androst-4-ene-3,6,17-triones.
Numazawa M; Mutsumi A; Asano N; Ito Y
Steroids; 1993 Jan; 58(1):40-6. PubMed ID: 8430444
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biochemical studies of 16- or 19-substituted androst-4-enes as aromatase inhibitors.
Numazawa M; Mutsumi A; Hoshi K; Oshibe M; Ishikawa E; Kigawa H
J Med Chem; 1991 Aug; 34(8):2496-504. PubMed ID: 1875347
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of androst-5-en-7-ones and androsta-3,5-dien-7-ones and their related 7-deoxy analogs as conformational and catalytic probes for the active site of aromatase.
Numazawa M; Mutsumi A; Tachibana M; Hoshi K
J Med Chem; 1994 Jul; 37(14):2198-205. PubMed ID: 8035427
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biochemical studies of 17-substituted androst-3-enes and 3,4-epoxyandrostanes as aromatase inhibitors.
Cepa MM; Tavares da Silva EJ; Correia-da-Silva G; Roleira FM; Teixeira NA
Steroids; 2008 Dec; 73(14):1409-15. PubMed ID: 18691607
[TBL] [Abstract][Full Text] [Related]
12. Studies on aromatase inhibition with 4-androstene-3,6,17-trione: its 3 beta-reduction and time-dependent irreversible binding to aromatase with human placental microsomes.
Numazawa M; Tsuji M; Mutsumi A
J Steroid Biochem; 1987 Sep; 28(3):337-44. PubMed ID: 3657156
[TBL] [Abstract][Full Text] [Related]
13. Aromatase inactivation by a suicide substrate, androst-5-ene-4,7,17-trione: the 5beta,6beta-epoxy-19-oxo derivative, as a possible reactive electrophile irreversibly binding to the active site.
Numazawa M; Tachibana M
Biol Pharm Bull; 1997 May; 20(5):490-5. PubMed ID: 9178927
[TBL] [Abstract][Full Text] [Related]
14. Steroidal inhibitors as chemical probes of the active site of aromatase.
Brueggemeir RW; Moh PP; Ebrahimian S; Darby MV
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):357-65. PubMed ID: 8476749
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human placental aromatase in a perfusion model. Comparison with kinetic, cell-free experiments.
Klein H; Bartsch W; Niemand A; Stürenburg HJ; Voigt KD
J Steroid Biochem; 1988 Feb; 29(2):161-9. PubMed ID: 3347056
[TBL] [Abstract][Full Text] [Related]
16. Studies directed toward a mechanistic evaluation of aromatase inhibition by androst-5-ene-7,17-dione. Time-dependent inactivation by the 19-nor and 5 beta, 6 beta-epoxy derivatives.
Numazawa M; Tachibana M
Steroids; 1997 Jul; 62(7):516-22. PubMed ID: 9253790
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of 19-aza- and 19-aminoandrostenedione analogues as potential aromatase inhibitors.
Lovett JA; Darby MV; Counsell RE
J Med Chem; 1984 Jun; 27(6):734-40. PubMed ID: 6547488
[TBL] [Abstract][Full Text] [Related]
18. Hydroperoxides as inactivators of aromatase: 10 beta-hydroperoxy-4-estrene-3,17-dione, crystal structure and inactivation characteristics.
Covey DF; Hood WF; Beusen DD; Carrell HL
Biochemistry; 1984 Nov; 23(23):5398-406. PubMed ID: 6509027
[TBL] [Abstract][Full Text] [Related]
19. Active-site-directed inactivation of aromatase from human placental microsomes by brominated androgen derivatives.
Bellino FL; Gilani SS; Eng SS; Osawa Y; Duax WL
Biochemistry; 1976 Oct; 15(21):4730-6. PubMed ID: 974087
[TBL] [Abstract][Full Text] [Related]
20. A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase.
Covey DF; Hood WF
Cancer Res; 1982 Aug; 42(8 Suppl):3327s-3333s. PubMed ID: 7083195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]